Braze, Inc. vs NVIDIA Corporation — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
9.1
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
BRZE
Consensus analyst target of $34.95 is 48% above current price.
⚠ currently unprofitable (-18% margin).
NVDA
Clean balance sheet with low leverage (0.1× debt-to-equity).
Analyst Consensus
BUY
Target $34.95 (+48.3%)
20 analysts
BUY
Target $269.17 (+35.6%)
57 analysts
Fundamentals
BRZE
NVDA
—
Trailing P/E
40.5×
24.0×
Forward P/E
17.7×
-17.8%
Profit Margin
55.6%
67.1%
Gross Margin
71.1%
-23.8%
ROE
101.5%
27.9%
Revenue Growth
73.2%
—
Earnings Growth
95.6%
0.89
Beta
2.33
—
Price / Book
—
$2.7B
Market Cap
$4.82T
$15 – $38
52-Week Range
$111 – $217
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →